Dr. Martens Regulatory News (DOCS)

14 July 2022

Dr. Martens plc - AGM Trading Update 

TRADING IN LINE WITH EXPECTIONS; FULL YEAR GUIDANCE REITERATED

Today, Dr. Martens plc will hold its Annual General Meeting at 0930 at Camden Wharf, 28 Jamestown Road, London, NW1 7BY.

Trading since the start of this financial year is in line with our expectations and the guidance set out at our year end results announcement for both the half year and the full year. The early months of our financial year are typically the smallest period of the year, representing the tail end of the spring/summer trading period.

In the three-month period, Ecommerce was in line with Q422, retail continued its strong recovery and our wholesale order book has continued to increase beyond 85% of the full year level as previously disclosed. We implemented the AW22 price increases fully from early July and to date have opened ten new stores. All our third-party factories are open and operating at 90-95% planned capacity, and shipping lead times continue to improve steadily.

Financial calendar

The next scheduled events are:

· Interim results 24 November 2022

· Q3 trading update 26 January 2023

· Full year results 01 June 2023

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

The Company listed successfully on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.